Last updated: 2026-09-05 00:55:40. Prices reflect the latest closing data and will resume updating on the next trading day. Stock price data is sourced from Massive.
Envoy Medical, Inc. (COCH) operates in the ORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUPPLIES sector and is listed on NASDAQ. The stock is currently priced at $0.71, with a market capitalization of $53.32M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $0.36 to $1.89. This page covers its latest market performance, valuation, price trends and company information.
$53.32M | |
$0.71 | |
$11.46 | |
$0.36 | |
$0.73 | |
27.59K | |
-- | |
-- | |
$1.89 | |
$0.36 | |
-- | |
-- |
Envoy Medical, Inc. (COCH) last closed at $0.73 as of 2026-09-04 23:31:00, unchanged from the previous close of $0.73.
During the latest regular trading session, COCH traded between $0.36 and $11.46, with a volume of 27.59K shares. The closing price was near the lower end and near the lower end of its 52-week range.
Over the past seven days, Envoy Medical, Inc. (COCH) moved from $0.69 to $0.71, representing a gain of 1.79% ($0.01).
The stock traded between $0.70 and $0.73 during the period. The latest price is near the lower end of the 7-day range, indicating moderate upward.
The average daily volume was 46.15 thousand shares, down versus the previous seven-day period, indicating lower trading activity.
Position in Range: 22.4%
COCH is currently trading at $0.71, placing it 22.4% of the way from its 52-week low of $0.36 to its 52-week high of $1.89. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
Envoy Medical Inc is a hearing health company focused on providing medical technologies across the hearing loss spectrum. Its product portfolio comprises: the Esteem FI-AMEI, a fully implanted active middle ear implant (FI -AMEI) that works with the ear's natural anatomy, and is FDA-approved for adults with moderate to severe sensorineural hearing loss; and Acclaim CI, an investigational cochlear implant under development. The company derives all of its revenue substantially from the sale of the Esteem FI-AMEI implants and their replacement components. It has one reportable segment: hearing.
| Industry | ORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUPPLIES |
| Employees | 47 |
| Exchange | NASDAQ |
| Company Website |
Eligible investors can buy real shares of Envoy Medical, Inc. (COCH) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.